Have a personal or library account? Click to login
Implementing new clinical pharmacy services parallel to the introduction of centralized preparation of anti-cancer drugs Cover

Implementing new clinical pharmacy services parallel to the introduction of centralized preparation of anti-cancer drugs

Open Access
|Jan 2011

References

  1. Institute for safe medication practices: ISMP's list of high-alert medications. Pridobljeno 19.11.2009 s spletne strani: http://www.ismp.org/Tools/highalertmedications.pdf
  2. Phillips J, Beam S, Brinker A, et al: Retrospective analysis of mortalities associated with medication errors. Am J Health Syst Pharm 2001; 58: 1835-1841.10.1093/ajhp/58.19.183511596700
  3. Sonc M. Standardi kakovosti za področje onkološke farmacevtske dejavnosti. Ljubljana: Lekarniška zbornica Slovenije, 2009.
  4. Department of Health: The NHS cancer plan. London, HMSO, No. 22293, 2001.
  5. Green E, Johnston M, Trudeau M, Schwartz L, Poirer S, Macartney G, Milliken D. Safe handling of parenteral cytotoxics: recommenations for Ontario. J Oncol Pract posted online ahead of print on August 20, 2009.10.1200/JOP.091014279067020856737
  6. North East London Cancer Network NHS: Guidelines on the safe prescribing, handling and administration of cytotoxic drugs. London, Department of Health Publications, 2005.
  7. American Society of Health System Pharmacists: ASHP guidelines on handling hazardous drugs. Am J Health Syst Pharm 2006; 63: 1172-1193.10.2146/ajhp050529
  8. Mort D, Lansdown M, Smith N, et al: For better, for worse? London, National Confidential Enquiry into Patient Outcome and Death, 2008.
  9. Knez L, Laaksonen R, Duggan C, et al: Evaluation of clinical interventions made by pharmacists in cancer services. Pharm J 2008; 280: 277-280.
  10. Goldspiel BR, DeChristoforo R, Daniels CE: A continuous-improvement approach for reducing the number of chemotherapy-related medication errors. Am J Health Syst Pharm 2000; 57: S4-9.10.1093/ajhp/57.suppl_4.S411148943
  11. Macintyre J, Dalrymple H, MacLean F, et al: Development of a system for reporting pharmaceutical care issues in cancer patients receiving chemotherapy. Pharm J 2003; 271: 266-267.
  12. Liekweg A, Westfeld M, Jaehde U: From oncology pharmacy to pharmaceutical care: new contributions to multidisciplinary cancer care. Support Care Cancer 2004; 12: 3-79.10.1007/s00520-003-0539-414530957
  13. Slama C, Jerome J, Jacquot C, et al: Prescription errors with cytotoxic drugs and inadequacy of existing classifications. Pharm World Sci 2005; 27: 339-343.10.1007/s11096-005-6034-x16228634
  14. Markert A, Thierry V, Kleber M, et al: Chemotherapy safety and severe adverse events in cancer patients: strategies to efficiently avoid chemotherapy errors in in- and outpatient treatment. Int J Cancer 2009; 124: 722-728.10.1002/ijc.2399118989899
  15. Bolnišnica Golnik KOPA. Pridobljeno 19.11.2009 s spletne strani: www.klinika-golnik.si
  16. Baza podatkov o zdravilih Republike Slovenije. Pridobljeno 4.12.2009 s spletne strani: www.zdravila.net
  17. European Medicines Agency: Human Medicines. Pridobljeno 4.12.2009 s spletne strani: www.emea.europa.eu
  18. Cancer Care Ontario: Cancer Drugs. Pridobljeno 4.12.2009 s spletne strani: http://www.cancercare.on.ca
  19. National Comprehensive Cancer Network: NCCN Chemotherapy Order Templates. Pridobljeno 4.12.2009 s spletne strani: http://www.nccn.org
  20. Kuhlmann MK, Burkhardt G, Köhler H: Insights into potential cellular mechanisms of cisplatin nephrotoxicity and their clinical application. Nephrol Dial Transplant 1997; 12: 2478-2480.10.1093/ndt/12.12.24789430835
  21. Roila F, Hesketh PJ, Herrstedt J; Antiemetic Subcommitte of the Multinational Association of Supportive Care in Cancer: Prevention of chemotherapy- and radiotherapy-indiced emesis: results of the 2004 Perugia Internetional Antiemetic Consensus Conference. Ann Oncol 2006; 17: 20-28.10.1093/annonc/mdj07816314401
  22. Floyd J, Mirza I, Sachs B, et al: Hepatotoxicity of chemotherapy. Semin Oncol 2006; 33: 50-67.10.1053/j.seminoncol.2005.11.00216473644
  23. Allan EL, Barker KN: Fundamentals of medication error research. Am J Hosp Pharm 1990; 47: 555-571.10.1093/ajhp/47.3.555
  24. Pajk B: Neželeni učinki sistemskega zdravljenja raka. Onkologija za prakso, 2007; 2: 131-138.
  25. Jaehde U, Liekwig A, Simos S, et al: Minimising treatment-associated risks in systemic cancer therapy. Pharm World Sci 2008; 30: 161-168.10.1007/s11096-007-9157-4225365217906939
DOI: https://doi.org/10.2478/v10152-010-0024-7 | Journal eISSN: 1854-2476 | Journal ISSN: 0351-0026
Language: English
Page range: 12 - 23
Published on: Jan 17, 2011
Published by: National Institute of Public Health, Slovenia
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year

© 2011 Lea Knez, Maja Jošt, Janez Toni, Nadja Triller, Tanja Čufer, published by National Institute of Public Health, Slovenia
This work is licensed under the Creative Commons License.

Volume 50 (2011): Issue 1 (March 2011)